Winstrol
Stanozolol
Oral stanozolol is a DHT-derived 17α-alkylated compound. Pack: 100 tablets × 20 mg; label 20–50 mg/day; half-life 9 hours. No aromatization or water retention on the sheet; hepatotoxicity and lipid strain are the main literature flags. Joint dryness is commonly noted in research anecdotes. Presented for laboratory research documentation only. Not for human consumption.
Quality Control
Identity, strength, and pack size on this listing follow the supplied product photography. Batch-specific laboratory documentation can be requested through the contact form. For laboratory research documentation only. Not for human consumption, diagnostic, or therapeutic use.
Research Background
Oral stanozolol is a DHT-derived 17α-alkylated compound. Pack: 100 tablets × 20 mg; label 20–50 mg/day; half-life 9 hours. No aromatization or water retention on the sheet; hepatotoxicity and lipid strain are the main literature flags. Joint dryness is commonly noted in research anecdotes. Presented for laboratory research documentation only. Not for human consumption.
Handling & Storage
Store at 20–25°C (room temperature). Protect from direct sunlight and freezing. Restricted laboratory access — keep out of reach of children and unauthorized users.
Quality Assurance
innov8pharma presents this material for laboratory documentation. Certificate of Analysis files can be requested per batch. Not for human consumption.
| Compound | Stanozolol (Winstrol) |
|---|---|
| Form | Oral tablets |
| Pack | 100 tablets × 20mg |
| Label dosage range | 20–50 mg/day |
| Water Retention | No |
| Aromatization | No |
| Half Life | 9 hours |
| HBR | Perhaps |
| Acne | Yes |
| Hepatotoxicity | Yes |
| Storage | 20–25°C |
